Our study demonstrated that sinisan significantly alleviated the symptoms of IBS-D and ameliorated intestinal dysfunction and depression-like behavior in mice, which may be achieved by inhibiting the TLR4/MyD88/NF-κB pathway. The gene discussed is MYD88; the disease is depressive symptom measurement.